Separation of β2-transferrin by denaturing gel electrophoresis to detect cerebrospinal fluid in ear and nasal fluids

Clinical Chemistry

Volumn 51, Issue 9, 2005, Pages 1704-1710

  Görögh, Tibor ^a   Rudolph, Pierre ^b   Meyer, Jens Eduard ^a   Werner, Jochen A ^c   Lippert, Burkard M ^c   Maune, Steffen ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 TRANSFERRIN; BETA2 TRANSFERRIN; PREALBUMIN; PROSTAGLANDIN D SYNTHASE; TRANSFERRIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; ISOPROTEIN;

ARTICLE; CEREBROSPINAL FLUID FISTULA; CEREBROSPINAL FLUID RHINORRHEA; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DISEASE MARKER; HUMAN; IMMUNOHISTOCHEMISTRY; LACRIMAL FLUID; LIQUORRHEA; MAJOR CLINICAL STUDY; MENINGITIS; NOSE MUCUS; OTORRHEA; POLYACRYLAMIDE GEL ELECTROPHORESIS; SALIVA; SERUM; WESTERN BLOTTING; CEREBROSPINAL FLUID; CHEMISTRY; EAR; ISOLATION AND PURIFICATION; NOSE; REPRODUCIBILITY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; CEREBROSPINAL FLUID OTORRHEA; CEREBROSPINAL FLUID RHINORRHEA; EAR; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; NOSE; PROTEIN ISOFORMS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SALIVA; SENSITIVITY AND SPECIFICITY; TEARS; TRANSFERRIN;

EID: 24144457528     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.054916     Document Type: Article

References (39)

1. Rouah E, Rogers BB, Buffone GJ. Transferrin analysis by immunofixation as an aid in the diagnosis of cerebrospinal fluid otorrhea. Arch Pathol Lab Med 1987;111:756-7.
2. 2 transferrin by polyacrylamide gel electrophoresis and immunoblotting. Clin Chem Clin Biochem 1989;27:169-72.
3. Blennow K, Fredman P. Detection of cerebrospinal fluid leakage by isoelectric focusing on polyacrylamide gels with silver staining using the PhastSystem. Acta Neurochir (Wien) 1995;136:135-9.
4. Ryall RG, Peacock MK, Simpson DA. Usefulness of β2-transferrin assay in the detection of cerebrospinal fluid leaks following head injury. J Neurosurg 1992;77:737-9.
5. Oberascher G, Arrer E. A new method for using fluorescein to demonstrate oto- and rhinoliquorrhea. Arch Otorhinolaryngol 1986;243:117-20.
6. Arrer E, Oberascher G, Gibitz HJ. Protein distribution in the perilymph. Acta Otolaryngol 1988;106:117-23.
7. Middelweerd MJ, de Vires N, Callioauw J, van Camp GJ. A new biochemical assay in the diagnostic management of nasal cerebrospinal fluid leakage. Eur Arch Otorhinolaryngol 1995;252: 336-9.
8. Zaret DL, Morrison N, Gulbranson R, Keren DF. Immunofixation to quantify β2 transferrin in cerebrospinal fluid to detect leakage of cerebrospinal fluid from skull injury. Clin Chem 1992;38:1908-12.
9. Huobore I, Huobore E, Pinoh CA. The discovery of transferrin in invertebrates. Protides Biol Fluids 1984;32:59-61.
10. Aisen P, Leibman A, Reich HA. Studies on the binding of iron to transferrin and conalbumin. J Biol Chem 1966;24:1666-71.
11. Fletcher J, Huehns ER. Significance of the binding of iron by transferrin. Nature 1967;215:584-6.
12. 59 to transferrin. Nucl Med 1963;1:111-8.
13. Yang F, Lumm JB, McGill JR, Moore CM, Naylor SL, van Bragt PH, et al. Human transferrin: cDNA characterization and chromosomal localization. Proc Natl Acad Sci USA 1984;8:2752-6.
14. McGillivray RTA, Mendez E, Shewal JG, Sinha SK, Lineback-Zins J, Brew K. The primary structure of human serum transferrin. The structures of seven cyanogen bromide fragments and the assembly of the complete structure. J Biol Chem 1983;258:3543-53.
15. De Jong G, van Dijk JP, van Eijk HG. The biology of transferrin. Clin Chim Acta 1990;190:1-46.
16. Saiz A, Graus F, Dalmau J, Pifarre A, Marin C, Tolosa E, et al. Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders. Ann Neurol 1999;46:774-7.
17. Contini C, Fainardi E, Cultrera R, Seraceni S, Castellazzi M, Peyron F, et al. Evidence of cerebrospinal fluid free kappa light chains in AIDS patients with Toxoplasma gondii encephalitis. J Neuroimmunol 2000;108:221-6.
18. Nagamitsu S, Matsuishi T, Yamashita Y, Yamada S, Kato H. Extrapontine myelinolysis with parkinsonism after rapid correction of hyponatremia: high cerebrospinal fluid level of homovanillic acid and successful dopaminergic treatment. Neural Transm 1999;106:949-53.
19. Meurman OH, Irjala K, Suonpaa J, Laurent B. A new method for the identification of cerebrospinal fluid leakage. Acta Otolaryngol 1979;87:366-9.
20. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-6.
21. Grunewald S, Huyben K, de Jong JG, Smeitink JA, Rubio E, Boers GH, et al. Beta-trace protein in human cerebrospinal fluid: a diagnostic marker for N-glycosylation defects in brain. Biochim Biophys Acta 1999;1455:54-60.
22. Tumani H, Nau R, Felgenhauer K. Beta-trace protein in cerebrospinal fluid: a blood-CSF barrier-related evaluation in neurological diseases. Ann Neurol 1998;44:882-9.
23. Yamashima T, Sakuda K, Tohma Y, Yamashita J, Oda H, Irikura D, et al. Prostaglandin D synthase (β-trace) in human arachnoid and meningioma cells: roles as a cell marker or in cerebrospinal fluid absorption, tumorigenesis, and calcification process. J Neurosci 1997;17:2376-82.
24. Oberascher G. A modern concept of cerebrospinal fluid diagnosis in oto-and rhinorrhea. Rhinology 1988;26:89-103.
25. Thalmann I, Kohut RI, Ryu JH, Thalmann R. High resolution two-dimensional electrophoresis: Technique and potential applicability to the study of inner ear disease. Am J Otol 1995;16: 153-7.
26. Knight JA. Advances in the analysis of cerebrospinal fluid. Ann Clin Lab Sci 1997;27:93-104.
27. Van Kamp GJ, Mulder K, Kuiper M, Wolters EC. Changed transferrin sialylation in Parkinson's disease. Clin Chim Acta 1995; 235:159-67.
28. Westermeyer R. Electrophoresis in practice, 1st ed. New York: VCH, 1993:277pp.
29. Oberascher G. Cerebrospinal fluid otorrhea. New trends in diagnosis. Am J Otol 1988;9:102-8.
30. Levenson MJ, Desloge RB, Parisier SC. Beta-2 transferrin: limitations of use as a clinical marker for perilymph. Laryngoscope 1966;106:159-61.
31. Kleine TO, Damm T, Althaus H. Quantification of β-trace protein and detection of transferrin isoforms in mixtures of cerebrospinal fluid and blood serum as models of rhinorrhea and otorrhea diagnosis. Fresenius J Anal Chem 2000;366:382-6.
32. Petren S, Vesterberg O. Concentration differences in isoforms of transferrin in blood from alcoholics during abuse and abstinence. Clin Chim Acta 1988;175:183-7.
33. Stibler H, Borg S. Glycoprotein glycosyltransferase activities in serum in alcohol-abusing patients and healthy controls. Scand J Clin Lab Invest 1991;51:43-51.
34. Bachmann G, Nekic M, Michel O. Clinical experience with β-trace protein as a marker for cerebrospinal fluid. Ann Otol Rhinol Laryngol 2000;109:1099-102.
35. Petereit HF, Bachmann G, Nekic M, Althaus H, Pukrop R. A new nephelomeric assay for β-trace protein (prostaglandin D synthase) as an indicator of liquorrhea. J Neurol Neurosurg Psychiatry 2001;71:347-51.
36. Arrer E, Meco C, Oberascher G, Piotrowski W, Albegger K, Patsch W. β-trace protein as a marker for cerebrospinal fluid rhinorrhea. Clin Chem 2002;48:939-41.
37. Bachmann G, Petereit H, Djenabi U, Michel O. Predictive values of β-trace protein (prostaglandin D synthase) by use of laser-nephelometry assay for the identification of cerebrospinal fluid. Neurosurgery 2002;50:571-6.
38. Davidsson P, Ekman R, Blennow K. A new procedure for detecting brain-specific proteins in cerebrospinal fluid. J Neural Transm 1997;104:711-20.
39. Marchi N, Fazio V, Cucullo L, Kight K, Masaryk T, Barnett G, et al. Serum transthyretin monomer as a possible marker of blood-to-CSF barrier disruption. J Neurosci 2003;23:1949-55.